AAAAAA

   
Results: 1-12 |
Results: 12
Staphylococcus aureus, T-cell repertoire, and Wegener's granulomatosis
Authors: Hamidou, MA Audrain, M Ninin, E Robillard, N Muller, JY Bonneville, M
Citation: Ma. Hamidou et al., Staphylococcus aureus, T-cell repertoire, and Wegener's granulomatosis, JOINT BONE, 68(5), 2001, pp. 373-377
Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses
Authors: Dobo, I Robillard, N Pineau, D Genevieve, F Piard, N Rapp, MJ Boasson, M Zandecki, M Hermouet, S
Citation: I. Dobo et al., Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses, ANN HEMATOL, 80(11), 2001, pp. 639-646
Immune response to antiretroviral treatment combining stavudine, didanosine and nevirapine
Authors: Reliquet, V Robillard, N Perre, P Muller, JY Raffi, F Audrain, M
Citation: V. Reliquet et al., Immune response to antiretroviral treatment combining stavudine, didanosine and nevirapine, PRESSE MED, 30(23), 2001, pp. 1143-1147
Famciclovir for ophthalmic tester: a randomised aciclovir controlled study
Authors: Tyring, S Engst, R Corriveau, C Robillard, N Trottier, S Van Slycken, S Crann, RA Locke, LA Saltzman, R Palestine, AG
Citation: S. Tyring et al., Famciclovir for ophthalmic tester: a randomised aciclovir controlled study, BR J OPHTH, 85(5), 2001, pp. 576-581
Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and Rta antigens by flow cytometry
Authors: Imbert-Marcille, BM Coste-Burel, M Robillard, N Foucaud-Gamen, J Billaudel, S Drouet, E
Citation: Bm. Imbert-marcille et al., Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and Rta antigens by flow cytometry, CL DIAG LAB, 7(2), 2000, pp. 206-211
Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF
Authors: Jego, G Avet-Loiseau, H Robillard, N Moreau, P Amiot, M Harousseau, JL Pellat-Deceunynck, C Bataille, R
Citation: G. Jego et al., Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF, LEUK RES, 24(7), 2000, pp. 627-630
IgG-secreting lymphoplasmacytoid leukaemia: a B-cell disorder with extensively mutated V-H genes undergoing Ig isotype-switching frequently associated with trisomy 12
Authors: Garand, R Sahota, SS Avet-Loiseau, H Talmant, P Robillard, N Moreau, A Gaillard, F Stevenson, FK Bataille, R
Citation: R. Garand et al., IgG-secreting lymphoplasmacytoid leukaemia: a B-cell disorder with extensively mutated V-H genes undergoing Ig isotype-switching frequently associated with trisomy 12, BR J HAEM, 109(1), 2000, pp. 71-80
Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy
Authors: Puthier, D Pellat-Deceunynck, C Barille, S Robillard, N Rapp, MJ Juge-Morineau, N Harousseau, JL Bataille, R Amiot, M
Citation: D. Puthier et al., Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy, LEUKEMIA, 13(2), 1999, pp. 289-294
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment
Authors: Derenne, S Amiot, M Barille, S Collette, M Robillard, N Berthaud, P Harousseau, JL Bataille, R
Citation: S. Derenne et al., Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment, J BONE MIN, 14(12), 1999, pp. 2048-2056
CD130 rather than CD126 expression is associated with disease activity in multiple myeloma
Authors: Barille, S Thabard, W Robillard, N Moreau, P Pineau, D Harousseau, JL Bataille, R Amiot, M
Citation: S. Barille et al., CD130 rather than CD126 expression is associated with disease activity in multiple myeloma, BR J HAEM, 106(2), 1999, pp. 532-535
Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells
Authors: Jego, G Robillard, N Puthier, D Amiot, M Accard, F Pineau, D Harousseau, JL Bataille, R Pellat-Deceunynck, C
Citation: G. Jego et al., Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells, BLOOD, 94(2), 1999, pp. 701-712
The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
Authors: Pellat-Deceunynck, C Barille, S Jego, G Puthier, D Robillard, N Pineau, D Rapp, MJ Harousseau, JL Amiot, M Bataille, R
Citation: C. Pellat-deceunynck et al., The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma, LEUKEMIA, 12(12), 1998, pp. 1977-1982
Risultati: 1-12 |